SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:liu-210668"
 

Sökning: onr:"swepub:oai:DiVA.org:liu-210668" > Spotlight on the 20...

  • Rienstra, MichielUniv Groningen, Netherlands (författare)

Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects

  • Artikel/kapitelEngelska2024

Förlag, utgivningsår, omfång ...

  • 2024-12-24
  • OXFORD UNIV PRESS,2024
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-210668
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-210668URI
  • https://doi.org/10.1093/europace/euae298DOI
  • https://ki.se/en/research/search-research-information?t=2&query=id%3A898076URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:for swepub-publicationtype

Anmärkningar

  • Funding Agencies|Dutch Heart Foundation; Dutch CardioVascular Alliance [01-002-2022-0118 EmbRACE]; ZonMW; Dutch Heart Foundation [848090001, CVON 2014-9, CVON2017-11]; Netherlands Cardiovascular Research Initiative; Top Sector Life Sciences and Health [2018B017]; European Union's Horizon 2020 research and innovation programme [945260]; British Heart Foundation [FS/CDRF/21/21032, PG/17/55/33087, AA/18/2/34218, FS/CDRF/21/21032)]; Bayer AG; Boehringer-Ingelheim (Stroke); DZHK; Boston Scientific; Medtronic; Abbott; Becton Dickenson; National Health and Medical Research Council of Australia; Pfizer; Bristol Myers Squibb; Daiichi Sankyo; Novartis; Amarin; Sanofi Aventis; BMS/Pfizer; Health Data Research UK; Medical Research Council; National Institutes of Health; Pfizer Innovative Target Exploration Network; Medtronic; AstraZeneca; Vifor International; Menarini; Abbott Laboratories; European Research Council (ERC) under the European Union [847770]; German Center for Cardiovascular Research (DZHK e.V.) [81Z1710103, 81Z0710114]; German Ministry of Research and Education [BMBF 01ZX1408A]; ERACoSysMed3 [031L0239]; European Research Council (ERC) under Horizon 2020, the European Union's Horizon Europe research programme [101095480]; EU, ERACoSysMed3 [031L0239]; European Union's Horizon 2020 research and innovation programme [847770]; Bayer Healthcare; Atricure; Sun Wave Pharma; National Institute for Health Research [NIHR CDF-2015-08-074 RATE-AF, NIHR130280 DaRe2THINK, NIHR132974 D2T-NeuroVascular]; National Institute for Health Research (Biomedical Research Centre) [NIHR203326]; EU/EFPIA Innovative Medicines Initiative [BigData@Heart 116074]; EU Horizon; UKRI [HYPERMARKER 101095480]; UK National Health Service Data for R&D Subnational Secure Data Environment Programme; UK Department for Business, Energy and Industrial Strategy Regulators Pioneer Fund; Cook and Wolstenholme Charitable Trust; European Society of Cardiology from Boehringer Ingelheim/BMS-Pfizer Alliance/Bayer/Daiichi Sankyo/Boston Scientific; NIHR/University of Oxford Biomedical Research Centre; British Heart Foundation/University of Birmingham Accelerator Award (STEEER-AF); Bayer; Amomed; Protherics Medicines Development
  • Atrial fibrillation (AF) remains the most common cardiac arrhythmia worldwide and is associated with significant morbidity and mortality. The European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery (EACTS) have recently released the 2024 guidelines for the management of AF. This review highlights 10 novel aspects of the ESC/EACTS 2024 Guidelines. The AF-CARE framework is introduced, a structural approach that aims to improve patient care and outcomes, comprising of four pillars: [C] Comorbidity and risk factor management, [A] Avoid stroke and thromboembolism, [R] Reduce symptoms by rate and rhythm control, and [E] Evaluation and dynamic reassessment. Additionally, graphical patient pathways are provided to enhance clinical application. A significant shift is the new emphasis on comorbidity and risk factor control to reduce AF recurrence and progression. Individualized assessment of risk is suggested to guide the initiation of oral anticoagulation to prevent thromboembolism. New guidance is provided for anticoagulation in patients with trigger-induced and device-detected sub-clinical AF, ischaemic stroke despite anticoagulation, and the indications for percutaneous/surgical left atrial appendage exclusion. AF ablation is a first-line rhythm control option for suitable patients with paroxysmal AF, and in specific patients, rhythm control can improve prognosis. The AF duration threshold for early cardioversion was reduced from 48 to 24 h, and a wait-and-see approach for spontaneous conversion is advised to promote patient safety. Lastly, strong emphasis is given to optimize the implementation of AF guidelines in daily practice using a patient-centred, multidisciplinary and shared-care approach, with the simultaneous launch of a patient version of the guideline.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Tzeis, StylianosMitera Hosp, Greece (författare)
  • Bunting, Karina VUniv Birmingham, England (författare)
  • Caso, ValeriaSanta Maria della Misericordia Univ Perugia, Italy (författare)
  • Crijns, Harry J. G. M.Maastricht Univ, Netherlands (författare)
  • De Potter, Tom J. R.Onze Lieve Vrouw Hosp, Belgium (författare)
  • Sanders, PrashanthanUniv Adelaide, Australia; Royal Adelaide Hosp, Australia (författare)
  • Svennberg, EKarolinska Univ Hosp MedH, Sweden,Department of Medicine, Huddinge (MedH)(Swepub:ki)e9179d2a5499e6fc797916f9c5e7ca1e (författare)
  • Casado-Arroyo, RubenUniv Libre Bruxelles, Belgium (författare)
  • Dwight, JeremyESC Patient Forum, France (författare)
  • Guasti, LuiginaUniv Insubria, Italy; ASST Settelaghi, Italy (författare)
  • Hanke, ThorstenAsklepios Klinikum Harburg, Germany (författare)
  • Jaarsma, TinyLinköpings universitet,Avdelningen för omvårdnad och reproduktiv hälsa,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US,Univ Med Ctr Utrecht, Netherlands(Swepub:liu)tinja77 (författare)
  • Lettino, MaddalenaFdn IRCCS San Gerardo dei Tintori, Italy (författare)
  • Lochen, Maja-LisaUiT Arctic Univ Norway, Norway; Univ Hosp North Norway, Norway (författare)
  • Lumbers, R. ThomasUCL, England; Barts Hlth NHS Trust, England; Univ Coll London Hosp NHS Trust, England (författare)
  • Maesen, BartMaastricht Univ, Netherlands (författare)
  • Molgaard, IngeESC Patient Forum, France (författare)
  • Rosano, Giuseppe M. C.San Raffaele Univ Rome, Italy; San Raffaele Cassino Hosp, Italy; St Georges Univ, England (författare)
  • Schnabel, Renate B.Univ Med Ctr Hamburg Eppendorf, Germany; German Ctr Cardiovasc Res DZHK, Germany (författare)
  • Suwalski, PiotrMinist Interior & Adm, Poland (författare)
  • Tamargo, JuanUniv Complutense, Spain (författare)
  • Tica, OtiliaUniv Birmingham, England; Bihor Cty Clin Emergency Hosp, Romania (författare)
  • Traykov, VassilAcibadem City Clin Tokuda Univ Hosp, Bulgaria (författare)
  • Kotecha, DipakUniv Birmingham, England; Univ Hosp Birmingham NHS Fdn Trust, England (författare)
  • Van Gelder, Isabelle C.Univ Groningen, Netherlands (författare)
  • Crijns, HJGM (författare)
  • Univ Groningen, NetherlandsMitera Hosp, Greece (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Europace: OXFORD UNIV PRESS26:121099-51291532-2092

Internetlänk

Hitta via bibliotek

  • Europace (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst. Hantera kakor

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy